4.5 Article

Swertia chirayita suppresses the growth of non-small cell lung cancer A549 cells and concomitantly induces apoptosis via downregulation of JAK1/STAT3 pathway

Related references

Note: Only part of the references are listed.
Article Immunology

Leishmanial CpG DNA nanovesicles: A propitious prophylactic approach against visceral leishmaniasis

Rohit Kumar Tiwari et al.

Summary: The study demonstrated the adjuvant properties of a novel CpG sequence found in the Leishmania donovani genome to enhance immune response. By combining parasite antigens with adjuvants and nanoparticle carriers, a significant cellular and humoral immune response was generated, reducing parasitic load in the liver, spleen, and bone marrow.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Review Oncology

p21 in Cancer Research

Bahar Shamloo et al.

CANCERS (2019)

Article Pharmacology & Pharmacy

In Vitro and In Vivo Antitumor Activity of Cucurbitacin C, a Novel Natural Product From Cucumber

Dinglan Wu et al.

FRONTIERS IN PHARMACOLOGY (2019)

Review Biochemistry & Molecular Biology

The emerging treatment landscape of targeted therapy in non-small-cell lung cancer

Min Yuan et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)

Review Oncology

Oxidation, glycation and glycoxidation-The vicious cycle and lung cancer

Saheem Ahmad et al.

SEMINARS IN CANCER BIOLOGY (2018)

Review Medicine, Research & Experimental

A systematic review of the protective role of swertiamarin in cardiac and metabolic diseases

Xin Yu Leong et al.

BIOMEDICINE & PHARMACOTHERAPY (2016)

Article Biochemistry & Molecular Biology

PTBP1 modulation of MCL1 expression regulates cellular apoptosis induced by antitubulin chemotherapeutics

J. Cui et al.

CELL DEATH AND DIFFERENTIATION (2016)

Review Oncology

Non-small cell lung cancer: current treatment and future advances

Cecilia Zappa et al.

TRANSLATIONAL LUNG CANCER RESEARCH (2016)

Article Biochemistry & Molecular Biology

STAT3 can serve as a hit in the process of malignant transformation of primary cells

M. Demaria et al.

CELL DEATH AND DIFFERENTIATION (2012)

Article Oncology

Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies

Pasquale Sansone et al.

JOURNAL OF CLINICAL ONCOLOGY (2012)

Review Pharmacology & Pharmacy

JAK2 the future: therapeutic strategies for JAK-dependent malignancies

Lindsay M. LaFave et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2012)

Review Cell Biology

STAT3 as a target for inducing apoptosis in solid and hematological tumors

Khandaker Al Zaid Siddiquee et al.

CELL RESEARCH (2008)

Review Cell Biology

Apoptosis: controlled demolition at the cellular level

Rebecca C. Taylor et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)

Article Chemistry, Medicinal

Inhibition of chronic skin inflammation by topical anti-inflammatory flavonoid preparation, Ato Formula®

Hyun Lim et al.

ARCHIVES OF PHARMACAL RESEARCH (2006)

Article Biochemistry & Molecular Biology

Role of Stat3 in regulating p53 expression and function

GL Niu et al.

MOLECULAR AND CELLULAR BIOLOGY (2005)

Article Biochemistry & Molecular Biology

Regulation of Bcl-2 and Bcl-xL anti-apoptotic protein expression by nuclear receptor PXR in primary cultures of human and rat hepatocytes

N Zucchini et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2005)

Article Medicine, General & Internal

A gain-of-function mutation of JAK2 in myeloproliferative disorders

R Kralovics et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Medicine, General & Internal

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

EJ Baxter et al.

LANCET (2005)

Article Chemistry, Multidisciplinary

Inhibition of STAT3 expression by siRNA suppresses growth and induces apoptosis in laryngeal cancer cells

LF Gao et al.

ACTA PHARMACOLOGICA SINICA (2005)